Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lemanski

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 14, 2018
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective studyA Dautruche, L Belin, P Cottu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, J P Pignon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 30, 2013
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 casesB Cutuli, C Lemanski, M Le Blanc-Onfroy, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancerA Dezellus, P Barriere, M Campone, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2004
[Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy]M Ychou, G Gory-Delabaere, P Blanc, et al.
Critical Reviews in Oncology/Hematology|May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 casesB Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 14, 2018
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective studyA Dautruche, L Belin, P Cottu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, J P Pignon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 30, 2013
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 casesB Cutuli, C Lemanski, M Le Blanc-Onfroy, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancerA Dezellus, P Barriere, M Campone, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2004
[Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy]M Ychou, G Gory-Delabaere, P Blanc, et al.
Critical Reviews in Oncology/Hematology|May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 casesB Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Pageof 4